Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

WuXi Biologics Signs $220 Million Bi-Specific Deal with ABL Bio of South Korea

publication date: Mar 4, 2019

In a $220 million agreement, South Korea's ABL Biotechnologies acquired rights to use WuXi Biologics' discovery platforms to develop multiple bispecific antibodies including new bispecific antibodies that target a novel immune check point receptor. WuXi Biologics, which will receive the $220 million in a combination of upfront and milestone payments, will also be paid royalties on any commercialized products from the partnership. ABL Bio will use WuXi's WuXiBody™ and CD3 platforms. The new partnership expands an existing agreement between the two companies announced in November 2018. More details....

Stock Symbols: (KS: 298380) (HK: 2269)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here